Abstract:Objective:To compare the diagnostic value of the American College of Radiology contrast-enhanced ultrasound liver imaging reporting and data system (ACR CEUS LI-RADS) and the World Federation for Ultrasound in Medicine and Biology-European Federation of Societies for Ultrasound in Medicine and Biology (WFUMB-EFSUMB) guidelines for hepatocellular carcinoma (HCC) in high-risk patients.Methods:From March 2018 to December 2020, 319 patients (334 lesions) with a high risk of HCC at the Second Affiliated Hospital Zhejiang University School of Medicine were analyzed. CEUS videos of 334 lesions were interpreted according to the CEUS LI-RADS 2017 edition and WFUMB-EFSUMB classification criteria. Using surgery or biopsy histopathology, clinical diagnosis, and follow-up results as reference standards, the diagnostic efficacy of each classification of ACR CEUS LI-RADS for HCC was analyzed. The sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and area under the ROC curve of ACR CEUS LI-RADS LR-5 and WFUMB-EFSUMB criteria in the diagnosis of HCC were calculated and compared by the chi-square test and DeLong's test. The area under the ROC curve of the combined diagnosis was also calculated and compared with that of either of them.Results:Of the 334 liver lesions included, according to the ACR CEUS LI-RADS classification, there were 114 nodules in LR-5 category, 25 in LR-4, 12 in LR-3, and 162 in LR-M; their positive predictive values for the diagnosis of HCC were 93.9%, 40.0%, 16.7%, and 24.7%, respectively. The sensitivity and specificity of ACR CEUS LI-RADS LR-5 and WFUMB-EFSUMB in the diagnosis of HCC were 66.9% vs 83.8% and 96.0% vs 73.0%, respectively, and the differences were statistically significant (χ2=25.037 and 38.025; P＜0.001). There was no significant difference in the diagnostic accuracy of the two criteria (82.0% vs 78.1%, χ2=1.352, P=0.245). The areas under the ROC curve were 0.814 and 0.784, respectively, and the difference was not statistically significant (P=0.161). The area under the ROC curve of the combined diagnosis of the two was 0.857, which was significantly higher than that of either of them (P=0.001 and <0.001, respectively).Conclusion:Both ACR CEUS LI-RADS and WFUMB-EFSUMB criteria have high diagnostic value for HCC in high-risk patients. The diagnostic efficacy of ACR CEUS LI-RADS LR-5 and WFUMB-EFSUMB is similar. However, the information provided by the two criteria is different, with ACR CEUS LI-RADS LR-5 having a higher specificity and WFUMB-EFSUMB having a higher sensitivity. The two criteria can complement each other to a certain extent.

Nodules Identified on Surveillance Ultrasound for HCC

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

Comparison Between ACR CEUS LI-RADS and WFUMB-EFSUMB for Diagnosing Hepatocellular Carcinoma in High-Risk Patients

Interobserver and inter-modalities agreement of contrast-enhanced ultrasound liver imaging reporting and data system(CEUS LI-RADS) and magnetic resonance imaging liver imaging reporting and data system(MRI LI-RADS) for hepatocellular carcinoma in high-risk patients

Response to Letter to the Editor Regarding the Article "Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement" by Zhou and Collaborators

Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography.

Clinical impact of contrast-enhanced ultrasound on indeterminate or non-characterizable liver nodules on CT/MRI: sub-analysis from a prospective multicenter trial

The comparison of contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI LI-RADS for nodules ≤2 cm in patients at high risk for HCC: a prospective study

On‐Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019–2022)

Diagnostic value of liver imaging reporting and data system for hepatocellular carcinoma by contrast-enhanced ultrasound

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS

Contrast-enhanced ultrasound versus contrast-enhanced MRI for diagnosis of well-differentiated hepatocellular carcinoma and precancerous lesions

Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients—a prospective multicenter study

A Multicenter Randomized Controlled Study of Contrast-enhanced US versus US-guided Biopsy of Focal Liver Lesions.

CT/MRI LI-RADS Version 2018 Versus CEUS LI-RADS Version 2017 in the Diagnosis of Primary Hepatic Nodules in Patients with High- Risk Hepatocellular Carcinoma

Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement

Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases

Comparison Of Contrast-Enhanced Ultrasound And Contrast-Enhanced Helical Ct In The Diagnosis Of High Echo-Level Small Focal Liver Lesions

Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.

Clinical Application of Liver Imaging Reporting and Data System for Characterizing Liver Neoplasms: A Meta-Analysis

The Role of Contrast-Enhanced Ultrasound on the Diagnosis of Small Hepatocellular Carcinoma (≤3cm) in Patients with Cirrhosis